Corporate Governance Reports
2018
-
(Dec 27, 2018)
For more information, click here
- About Chugai
- Message from the CEO
- Corporate Governance
- Chugai’s Seven Strengths
- Company Outline
- Company Profile
- Value Creation Model
- Business Processes
- Directors & Officers
- Organization
- Company Brochure & Reports
- Our Vision
- Our Strategy
- R&D
- Overview of Chugai’s Research Activities
- R&D Strategy
- Features of Research Platform
- Research Structure
- Our Proprietary Technologies
- Clinical Development
- Intellectual Property
- Other Guidelines
- Chugai R&D Glossary
- Videos & Advertisements
- 90 Years History of Chugai Pharmaceutical
- Foundation
- Growth after World War II
- Shift to Prescription Drugs
- Challenge to BIO
- Alliance with Roche
- Chugai Group
- Media Conference
- News
- Investor Relations
- Management Policy
- Message from the CEO
- Mission Statement
- Mid-Term Business Plan
- Directors & Officers
- Corporate Governance
- Business Risk
- Disclosure Policy
- Financial Results
- Latest Results
- Income Statement
- Revenue by Product
- Movements of assets and liabilities
- Movements of Free Cash Flows
- Performance Indicators
- Reports & Downloads
- Quarterly Reports
- Development Pipeline
- Presentation Materials
- Corporate Governance Reports
- Downloads
- Shareholder Information
- Notices
- Shareholder Meetings
- Information on Shares
- Shareholder Returns
- Share Ownership
- Analyst Coverage
- Bonds & Ratings
- Share Price
- R&D
- Company Outline
- 90 Years History of Chugai Pharmaceutical
- Foundation
- Growth after World War II
- Shift to Prescription Drugs
- Challenge to BIO
- Alliance with Roche
- ESG at Chugai
- See how Chugai compares to other companies
- Strategic Alliance with Roche
- Chugai’s Seven Strengths
- Events & Presentations
- Contacts & Information
- FAQs
- Management Policy
- Recruitment
- CSR
- Chugai's Approach to CSR
- Message from the Deputy Chairman of the Board
- Mission Statement and Chugai Group Code of Conduct
- CSR (Corporate Social Responsibility) at Chugai Pharmaceutical
- Our Commitment to Corporate Ethics
- Initiatives and Performance
- Chugai's Transparency Guidelines
- Guidelines on Relation with Medical Institutions and Patient Groups
- Disclosure of Information According to the "Transparency Guidelines for Chugai Activities Involving Medical Institutions, etc."
- Disclosure of Information According to the "Guidelines for Cooperation Between Chugai and Patient Groups"
- Initiatives for Patients and Consumers
- Working with Business Partners
- Initiatives for Society
- Engagement with Employees
- Environmental Protection, Safety and Health
- Basic Approach and Policy
- Promotional Activities and Support
- Goals and Initiatives
- Health and Safety Activities
- Climate Change Countermeasures
- Waste and Recycling
- Chemical Substance Management
- Prevention of Air, Water and Soil Pollution
- Education, Communication and Environmental Accounting
- Diversity and Inclusion Initiatives
- Envisioned Future and Performance
- Diversity and Inclusion Promotion System
- Initiatives to Promote the Success of Diverse Employees
- Facilitating Work/Life Balance
- Performance Data Related to Diversity and Inclusion
- Performance Data
- Past Reports and Special Features
- Response in Emergencies
- Activities related to the Great East Japan Earthquake
- Action Plan for Pandemic Influenza and New Infectious Diseases
- CSR Viewing Policy
- Chugai's Approach to CSR
- Contact
